Basic leucine zipper ATF-like transcription factor (BATF) as a candidate marker associated with venous thromboembolism risk factors in sepsis: an integrated bioinformatics and machine learning analysi
Source check: Source checked. Not independent scientific confirmation.
Finding: Full primary text shows transcriptomic ML and cohort analyses nominate BATF, with ROC/Cox associations across datasets; authors explicitly state no adjudicated or imaging-confirmed VTE outcome was studied. Candidate biomarker signal only, not diagnosis or direct thrombosis prediction.
Technology: Transcriptomic machine learning and cross-cohort expression analyses nominated BATF as a candidate signal associated with VTE risk factors in sepsis.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Transcriptomic machine learning and cross-cohort expression analyses nominated BATF as a candidate signal associated with VTE risk factors in sepsis.
- Test and result
- Full primary text shows transcriptomic ML and cohort analyses nominate BATF, with ROC/Cox associations across datasets; authors explicitly state no adjudicated or imaging-confirmed VTE outcome was studied. Candidate biomarker signal only, not diagnosis or direct thrombosis prediction. Evaluation: Original Methods/Results establish the case-specific cohort/experiment, comparator, and validation limitations as summarized in reason.
- Limitation / still unknown
- The study did not use adjudicated or imaging-confirmed venous-thromboembolism outcomes; BATF is a candidate biomarker signal, not a diagnostic or direct thrombosis prediction.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13693607/?report=reader
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.